Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell Non-Hodgkin Lymphoma (iNHL)

被引：0

作者：

Dreyling, M. H. ^{[1
]}

Viardot, A. ^{[2
]}

Salles, G. ^{[3
]}

Wagner-Johnston, N. D. ^{[4
]}

Kahl, B. S. ^{[5
]}

De Vos, S. ^{[6
]}

Schuster, S. J. ^{[7
]}

Jurczak, W. ^{[8
]}

Flinn, I. W. ^{[9
]}

Flowers, C. ^{[10
]}

Martin, P. ^{[11
]}

Blum, K. A. ^{[12
]}

Davies, A. J. ^{[13
]}

Zinzani, P. L. ^{[14
]}

Wagner, L., I ^{[15
]}

Gopal, A. K. ^{[16
]}

Ruppert, S. ^{[17
]}

Kroenig, H. ^{[17
]}

Schuster, A. ^{[17
]}

机构：

[1] Klinikum Univ Munchen, Med Klin & Poliklin 3, Munich, Germany

[2] Univ Hosp Ulm, Ulm, Germany

[3] Lyon Sud Univ Hosp, Lyon, France

[4] Washington Univ Sch Med, St Louis, MO USA

[5] Univ Wisconsin Carbone Canc Ctr, Madison, WI USA

[6] Univ Calif Los Angeles, Los Angeles Med Ctr, Los Angeles, CA USA

[7] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[8] Jagiellonian Univ, Krakow, Poland

[9] Sarah Cannon Res Inst, Nashville, TN USA

[10] Emory Univ, Atlanta, GA 30322 USA

[11] Weill Cornell Med Coll, New York, NY USA

[12] Ohio State Univ, Columbus, OH 43210 USA

[13] Univ Southampton, Southampton, Hants, England

[14] Univ Bologna, Bologna, Italy

[15] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[16] Univ Washington, Seattle, WA 98195 USA

[17] Gilead Sci GmbH, Martinsried, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷

关键词：

NHL; Outcome measurement; PI3K;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V573

引用

页码：185 / 185

页数：1